Volume 12, Number 5—May 2006
THEME ISSUE
Tuberculosis Special Section
Research
Tuberculosis Transmission Attributable to Close Contacts and HIV Status, Malawi
Amelia C. Crampin*†, Judith R. Glynn*
, Hamidou Traore*, Malcolm D. Yates‡, Lorren Mwaungulu†, Michael Mwenebabu†, Steven D. Chaguluka†, Sian Floyd*, Francis Drobniewski‡, and Paul E.M. Fine*
, Hamidou Traore*, Malcolm D. Yates‡, Lorren Mwaungulu†, Michael Mwenebabu†, Steven D. Chaguluka†, Sian Floyd*, Francis Drobniewski‡, and Paul E.M. Fine*
Table 2
Probability of transmission from a smear-positive putative source contact (PSC) being confirmed by restriction fragment length polymorphism, according to characteristics of case and PSC
| Characteristic | Confirmed/ total pairs (%) | p | Odds ratio, 95% confidence interval (adjusted for closeness of contact) | |
|---|---|---|---|---|
| Closeness of contact | ||||
| Same household | 22/50 (44.0) | 3.6 (1.4–9.3) | ||
| Close family, not household | 17/38 (44.7) | 3.5 (1.5–8.6) | ||
| Other | 10/55 (18.2) | 0.006 | Referent | |
| Time between diagnosis of disease in PSC and case-patient (mo) | ||||
| <12 | 21/62 (33.9) | Referent | ||
| 12–23 | 13/36 (36.1) | 1.1 (0.44–2.6) | ||
| >24 | 15/45 (33.3) | 1.0 | 0.88 (0.37–2.1) | |
| Age of case-patient (y) | ||||
| <30 | 20/53 (37.7) | Referent | ||
| 30–44 | 23/67 (34.3) | 0.72 (0.32–1.6) | ||
| >45 | 6/23 (26.1) | 0.3 (trend) | 0.48 (0.17–1.3) | |
| Age of PSC (y) | ||||
| <30 | 20/49 (40.8) | Referent | ||
| 30–44 | 21/63 (33.3) | 0.93 (0.42–2.1) | ||
| >45 | 8/31 (25.8) | 0.2 (trend) | 0.59 (0.19–1.8) | |
| Sex of case-patient | ||||
| Female | 28/81 (34.6) | 0.9 | Referent | |
| Male | 21/62 (33.9) | 1.2 (0.56–2.4) | ||
| Sex of PSC | ||||
| Female | 33/75 (44.0) | 0.01 | Referent | |
| Male | 16/68 (23.5) | 0.46 (0.21–0.99) | ||
| HIV status of case-patient | ||||
| HIV negative | 16/37 (43.2) | 0.1 | Referent | |
| HIV positive | 19/67 (28.4) | 0.55 (0.23–1.3) | ||
| HIV status of PSC | ||||
| HIV negative | 27/59 (45.8) | 0.01 | Referent | |
| HIV positive | 15/62 (24.2) | 0.32 (0.14–0.74) | ||
| Drug resistance of PSC | ||||
| None | 42/129 (32.6) | 0.2 | Referent | |
| Isoniazid resistant | 7/14 (50.0) | 2.1 (0.66–6.8) | ||
| Smear positivity of PSC | ||||
| 1+ | 5/18 (27.8) | Referent | ||
| 2+ | 12/36 (33.3) | 0.94 (0.26–3.5) | ||
| 3+ | 12/43 (27.9) | 0.89 (0.25–3.2) | ||
| 4+ | 20/46 (43.5) | 0.4 | 1.6 (0.46–5.4) | |
Page created: January 12, 2012
Page updated: January 12, 2012
Page reviewed: January 12, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.